Artificial Intelligence Used in Screening Adrenal Nodules
NCT ID: NCT07198152
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2025-09-01
2027-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
NCT04941560
Using Cardiac MRI to Predict Outcomes in Patients With STEMI
NCT07072858
The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
NCT07330362
Deep Learning CAD Screening on Chest CT
NCT07181512
Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography
NCT06025305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nodular adrenal glands
Adrenal region segmentation and adrenal nodule identification in chest CT via artificial intelligence
None intervention
this study is retrospective based on the CT images, which dose include any intervention.
Normal adrenal glands
Adrenal region delineation and adrenal gland identification in chest CT using artificial intelligence
None intervention
this study is retrospective based on the CT images, which dose include any intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None intervention
this study is retrospective based on the CT images, which dose include any intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Images from chest low-dose CT plain scan during routine physical examination;
Exclusion Criteria
2. Imaging images with poor quality, artifacts, etc., which make analysis impossible.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Peking University First Hospital
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
MR-11-23-010450
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022yan068-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.